Effect of eprosartan and enalapril in the treatment of black hypertensive patients: Subgroup analysis of a 26-week, double-blind, multicentre study

Current Medical Research and Opinion

Volumn 15, Issue 1, 1999, Pages 25-32

  Levine, B ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin II antagonist; Angiotensin converting enzyme (ACE) inhibitors; Black hypertensive patients; Enalapril; Eprosartan

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENALAPRIL; EPROSARTAN; HYDROCHLOROTHIAZIDE;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTENSION; IMPOTENCE; MALE; MICTURITION DISORDER; MULTICENTER STUDY; MYALGIA; NEGRO; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SINGLE BLIND PROCEDURE; UPPER RESPIRATORY TRACT INFECTION;

EID: 0032930222     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007999909115170     Document Type: Article

References (20)

1. National High Blood Pressure Education Program Working Group. (1993). National High Blood Pressure Education Program Working Group on primary prevention of hypertension. Arch. Intern. Med., 153, 186-208.
2. Lackland, D. T. and Keil, J. E. (1996). Epidemiology of hypertension in African Americans. Semin. Nephrol., 16, 63-70.
3. Kenton, E. J. III (1996). Diagnosis and treatment of concomitant hypertension and stroke. J. Natl. Med. Assoc., 88, 364-368.
4. Walker, W. G. (1993). Hypertension-related renal injury: a major contributor to end-stage renal disease. Am. J. Kidney. Dis., 22, 164-173.
5. Weinberger, M. H. (1996). Hypertension in African Americans: The role of sodium chloride and extracellular fluid volume. Semin. Nephrol., 16, 110-116.
6. Williams, G. H. (1988). Converting enzyme inhibitors in the treatment of hypertension. N. Engl. J. Med., 319, 1517-1525.
7. Materson, B. J., Reda, D. J., Cushman, W. C., et al. (1993). Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo. N. Engl. J. Med., 328, 914-921.
8. Campese, V. M., Parise, M., Karubin, F. and Bigazzi, R. (1991). Abnormal renal hemodynamics in black salt sensitive patients with hypertension. Hypertension, 18, 805-821.
9. Hall, W. D. (1990). Pathophysiology of hypertension in blacks. Am. J. Hypertens., 3, 366S-371S.
10. Weir, M. R, Gray, J. M., Pater, R. and Saunders, E. (1995). Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients: The Trandolapril Multicenter Study Group. Hypertension, 26, 124-130.
11. Saunders, E., Weir, M. R., Kong, B. W., et al. (1990). A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch. Intern. Med., 150, 1707-1713.
12. Nishimura, I. I., Hoffman, S., Baltatu, O., Sugimura, K., Ganten, D. and Urata, H. (1996). Angiotensin-I-converting-enzyme and chymase in cardiovascular tissues. Kidney Int., 49 (Suppl), S18-S23.
13. Hollenberg, N. K. and Fisher, N. D. L. (1995). Renal circulation and blockade of the renin-angiotensin system. Hypertension, 26, 602-609.
14. Burnier, M., Buclin, T., Biollaz, B., Nussberger, J., Waeber, B. and Brunner, H. R. (1996). Pharmacokinetic-pharmacodynamic relationships of three angiotensin II receptor antagonists in normal volunteers. Kidney Int., 49 (Suppl), S24-S29.
15. Elliott, W. (1999). Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. J. Hum. Hypertens., in press.
16. Hedner, T. and Himmelmann, A. (1998). The efficacy and tolerance of once- and twice-daily eprosartan in essential hypertension. J. Hypertens., in press.
17. Dunn, F. G., Oigman, W., Ventura, H. O., Messerli, F. H., Kobrin, I. and Frohlich, E. D. (1984). Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am. J. Cardiol., 53, 105-108.
18. Maki, D. D., Ma, J. Z., Louis, T. A. and Kasiske, B. L. (1995). Effects of antihypertensive agents on the kidney. Arch. Int. Med., 155, 1073-1082.
19. Israili, Z. H. and Hall, W. D. (1992). Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology. Ann. Intern. Med., 117, 234-242.
20. Kreft-Jais, C., Laforest, L., Bonnardeaux, A., Dumont, C., Plouin, P-F. and Jeunemaitre, X. (1994). ACE inhibitors, cough, and genetics. Lancet, 343, 740 (letter).